Your browser doesn't support javascript.
loading
Low-Dose Rifabutin Increases Cytotoxicity in Antimitotic-Drug-Treated Resistant Cancer Cells by Exhibiting Strong P-gp-Inhibitory Activity.
Lee, Ji Sun; Oh, Yunmoon; Kim, Hyung Sik; Yoon, Sungpil.
Affiliation
  • Lee JS; School of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon 16419, Korea.
  • Oh Y; School of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon 16419, Korea.
  • Kim HS; School of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon 16419, Korea.
  • Yoon S; School of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon 16419, Korea.
Int J Mol Sci ; 23(13)2022 Jul 02.
Article in En | MEDLINE | ID: mdl-35806386
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Antimitotic Agents / Neoplasms Limits: Humans Language: En Journal: Int J Mol Sci Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Antimitotic Agents / Neoplasms Limits: Humans Language: En Journal: Int J Mol Sci Year: 2022 Document type: Article